OT - you're rather emotional. MSB is not going to move until it has news. Then it can be a good trading stock, regardless of whether the news is good or bad. After an announcement, there is always volume and volatility. As for being a sell, that ship has sailed. IMO it's more of a buy at the moment but definitely a punt as you never know if the next lot of news will be positive or negative but the recent history is skewed toward the negative. They must be very close to Novartis news which most definitely could go any way.
